GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates.
The recent H5N1 avian and H1N1 swine-origin influenza virus outbreaks reaffirm that the threat of a world-wide influenza pandemic is both real and ever-present. Vaccination is still considered the best strategy for protection against influenza virus infection but a significant challenge is to identi...
Main Authors: | Peter T Loudon, Eric J Yager, Debbie T Lynch, Amithi Narendran, Cristy Stagnar, Anthony M Franchini, James T Fuller, Phil A White, Julia Nyuandi, Clayton A Wiley, Michael Murphey-Corb, Deborah H Fuller |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-06-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2882341?pdf=render |
Similar Items
-
Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaques.
by: Deborah Heydenburg Fuller, et al.
Published: (2012-01-01) -
SOCS-1 mediates ubiquitylation and degradation of GM-CSF receptor.
by: Severa Bunda, et al.
Published: (2013-01-01) -
GM-CSF signalling boosts dramatically IL-1 production.
by: Hanif Javanmard Khameneh, et al.
Published: (2011-01-01) -
Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
by: Hillard M. Lazarus, et al.
Published: (2023-01-01) -
Immune Evasion of G-CSF and GM-CSF in Lung Cancer
by: Yeonhee Park, et al.
Published: (2024-01-01)